HOME > BUSINESS
BUSINESS
- Santen’s Myopia Drug Ryjunea Now Available in Germany
July 23, 2025
- Moderna Drops Plan for mRNA API Site in Japan as Vaccine Demand Slumps
July 22, 2025
- Sanofi to Take Over Japan MA for Beyfortus from AstraZeneca
July 22, 2025
- Multi-Dose Wegovy Pen Now Available in Japan: Novo
July 22, 2025
- Enhertu Combo Gets Breakthrough Tag for First-Line HER2 Breast Cancer
July 22, 2025
- Nippon Chemiphar Signs On to Meiji-Daito Consortium as Talks Accelerate
July 22, 2025
- Ex-Finance Official Says Treating Obesity Could Lower Japan’s Healthcare Costs
July 22, 2025
- JRI Urges Reforms in Pricing and Reimbursement to Support Regenerative Medicine Ecosystem
July 18, 2025
- Astellas Partners with KISED to Support Korean Biotech Startups
July 18, 2025
- Kowa Picks Up Global Rights to Nicox’s Glaucoma Drug Excluding Asia
July 18, 2025
- Alnylam’s Amvuttra Could Become First-Line Therapy for ATTR-CM, Says Expert
July 18, 2025
- Otsuka Taps Autoimmune Diseases as Strategic Pillar for Long-Term Growth
July 17, 2025
- Nihon Medi-Physics to Deepen Theranostics Ties with Pharma under GE HealthCare
July 17, 2025
- Balversa Launched in Japan as 1st Genetically Targeted Drug for Bladder Cancer: J&J
July 17, 2025
- Towa Resumes Packaging Operations at Fire-Hit Yamagata Facility
July 17, 2025
- Nobelpharma’s Pediatric Sleep Aid Melatonin Wins Nod in China
July 17, 2025
- Fire Breaks Out at Towa’s Yamagata Plant, Production Halted at One Building
July 16, 2025
- JCR, Acumen Hook Up to Develop BBB-Penetrating Alzheimer’s Therapy
July 16, 2025
- Otsuka Bags Autoimmune Antibody Drug from Swedish Biotech
July 16, 2025
- Global Pharma Market Surges 9% to US$1.6 Trillion in 2024, Ozempic Overtakes Humira: IQVIA
July 16, 2025
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
